The Spain In Silico Clinical Trials Market is anticipated to exceed USD 225.6 Million by 2033, growing at a CAGR of 7.02% from 2023 to 2033. The increasing technological advancement, regulatory support, and faster drug development are driving the growth of the in silico clinical trials market in the Spain.